The North America Hemostats Market is expected to witness market growth of 4.8% CAGR during the forecast period (2022-2028).
The demand for the hemostats devices is also driven by an increase in the number of surgeries in a variety of fields, including orthopaedic, gynaecological, reconstructive, and cardiac surgery as well as an increase in the number of cancers that require surgical procedures. Additionally, throughout the forecast period, new innovations by key competitors and an increase in the number of product approvals for hemostasis devices are anticipated to create significant prospects for the market.
Hemostatic forceps often feature serrations along the jaw and are curved or straight to grab both small and large blood vessels. During a surgical operation, they are also utilised to grab medium to heavy tissue. These forceps contain a ratchet-style locking mechanism that is used to clamp blood arteries. These are routinely employed during surgical procedures, especially during complicated surgeries. Hemostats also are available in a different form for use in surgery, where these products are used to treat surgical incisions and wounds. These are simple for doctors to employ and come in the form of topical hemostats or sealants.
The industry has benefited from the government's reimbursement regulations in the North American region. For wound and incision closure, tissue sealants, tissue adhesives, and adhesion prevention techniques have taken the place of conventional sutures. The expansion of the regional hemostats market is anticipated to be aided by the burgeoning medical tourism industry, rising purchasing power, quickly growing healthcare infrastructure, and rising public knowledge of healthcare procedures. Along with this, more hospitals and surgical centers, more emerging markets, and increased industry research and development efforts is expected to open up lucrative opportunities for the adoption of hemostatic.
The US market dominated the North America Hemostats Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $951.3 million by 2028. The Canada market is poised to grow at a CAGR of 7.2% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 6.2% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
The demand for the hemostats devices is also driven by an increase in the number of surgeries in a variety of fields, including orthopaedic, gynaecological, reconstructive, and cardiac surgery as well as an increase in the number of cancers that require surgical procedures. Additionally, throughout the forecast period, new innovations by key competitors and an increase in the number of product approvals for hemostasis devices are anticipated to create significant prospects for the market.
Hemostatic forceps often feature serrations along the jaw and are curved or straight to grab both small and large blood vessels. During a surgical operation, they are also utilised to grab medium to heavy tissue. These forceps contain a ratchet-style locking mechanism that is used to clamp blood arteries. These are routinely employed during surgical procedures, especially during complicated surgeries. Hemostats also are available in a different form for use in surgery, where these products are used to treat surgical incisions and wounds. These are simple for doctors to employ and come in the form of topical hemostats or sealants.
The industry has benefited from the government's reimbursement regulations in the North American region. For wound and incision closure, tissue sealants, tissue adhesives, and adhesion prevention techniques have taken the place of conventional sutures. The expansion of the regional hemostats market is anticipated to be aided by the burgeoning medical tourism industry, rising purchasing power, quickly growing healthcare infrastructure, and rising public knowledge of healthcare procedures. Along with this, more hospitals and surgical centers, more emerging markets, and increased industry research and development efforts is expected to open up lucrative opportunities for the adoption of hemostatic.
The US market dominated the North America Hemostats Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $951.3 million by 2028. The Canada market is poised to grow at a CAGR of 7.2% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 6.2% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
By Formulation
- Matrix & Gel
- Sheet & Pad
- Powder
- Sponge
- Others
By Type
- Thrombin Based
- Combination
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Hemostats Market by Application
Chapter 4. North America Hemostats Market by Formulation
Chapter 5. North America Hemostats Market by Type
Chapter 6. North America Hemostats Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
Methodology
LOADING...
